Disease Intelligence
Epilepsy
Epilepsy: 107 indexed trials, 22 recruiting studies, 91 sponsors and 27 countries in the current NeuroRisk corpus.
Request Epilepsy enterprise brief →Indexed trials107
Recruiting22
Sponsors91
Countries27
Analytical signals
Opportunity89.93
Momentum101.93
Publications16
2030 signal203.86
Model-derived signals require context and are not medical advice or guaranteed forecasts.
Leading indexed sponsors
Cyberonics, Inc.3 indexed studies0 recruiting
UCB Pharma3 indexed studies0 recruiting
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3 indexed studies0 recruiting
Supernus Pharmaceuticals, Inc.3 indexed studies1 recruiting
Rennes University Hospital2 indexed studies0 recruiting
Universiteit Antwerpen2 indexed studies0 recruiting
Ataturk University2 indexed studies1 recruiting
NYU Langone Health2 indexed studies0 recruiting
Eisai Inc.2 indexed studies1 recruiting
King's College London2 indexed studies0 recruiting
Bial - Portela C S.A.2 indexed studies0 recruiting
Hospices Civils de Lyon2 indexed studies1 recruiting
Enterprise intelligence
Unlock comparative analysis, exports, API workflows and evidence-linked briefs tailored to your organization.
Request enterprise access →